다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

LUMO

Lumos Pharma (LUMO)

Lumos Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LUMO

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/06	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUMO	Lumos Pharma Inc
2024/06/05	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/06/04	22:00	GlobeNewswire Inc.	Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024	NASDAQ:LUMO	Lumos Pharma Inc
2024/05/21	05:05	GlobeNewswire Inc.	Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024	NASDAQ:LUMO	Lumos Pharma Inc
2024/05/15	22:57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUMO	Lumos Pharma Inc
2024/05/15	05:15	GlobeNewswire Inc.	Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results	NASDAQ:LUMO	Lumos Pharma Inc
2024/05/10	03:51	GlobeNewswire Inc.	Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024	NASDAQ:LUMO	Lumos Pharma Inc
2024/04/19	05:05	GlobeNewswire Inc.	Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings	NASDAQ:LUMO	Lumos Pharma Inc
2024/03/20	21:00	GlobeNewswire Inc.	Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042	NASDAQ:LUMO	Lumos Pharma Inc
2024/03/08	06:48	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:LUMO	Lumos Pharma Inc
2024/03/08	06:44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUMO	Lumos Pharma Inc
2024/03/08	06:01	GlobeNewswire Inc.	Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/26	23:00	GlobeNewswire Inc.	Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/08	07:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/07	06:02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/06	07:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/06	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/06	07:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/06	07:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/06	07:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/02/06	06:05	GlobeNewswire Inc.	Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference	NASDAQ:LUMO	Lumos Pharma Inc
2024/01/11	09:03	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:LUMO	Lumos Pharma Inc
2024/01/05	06:34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUMO	Lumos Pharma Inc
2024/01/05	06:05	GlobeNewswire Inc.	Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer	NASDAQ:LUMO	Lumos Pharma Inc
2023/11/30	06:30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:LUMO	Lumos Pharma Inc
2023/11/22	06:15	GlobeNewswire Inc.	Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency	NASDAQ:LUMO	Lumos Pharma Inc
2023/11/21	06:05	GlobeNewswire Inc.	Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November	NASDAQ:LUMO	Lumos Pharma Inc
2023/11/16	06:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUMO	Lumos Pharma Inc
2023/11/08	08:24	Dow Jones News	Lumos Pharma Shares Than Double After Hormone Deficiency Trial Meets All Endpoints	NASDAQ:LUMO	Lumos Pharma Inc
2023/11/08	07:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LUMO	Lumos Pharma Inc

검색 관련기사 보기:NASDAQ:LUMO

1 2 3 4 5 6 7 8 9 다음 >>

American Express

Bank of America

US Dollar vs Sterling

Invesco QQQ Trust Series 1

US Dollar vs Yen

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관